Breathtec BioMedical Inc.

(BTH:CNX)

By |
Breathtec BioMedical Inc.

Profile

Breathtec Biomedical, Inc. (“Breathtec”) was formed to propel innovative research in the area of breath analysis as a medical screening tool. Our efforts are aimed at leading the development of commercially viable methods for the early screening of diseases such as lung & breast cancers, neurodegenerative diseases (eg: Alzheimer’s / Parkinson’s), tuberculosis, diabetes, liver disease and more.

Issuer Information

Exchange: CNQ
CEO: Guy LaTorre
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: In-Vitro Diagnos
$ 0.14 $ -0.01 (-6.67%)
Last Price 0.14 Change $ -0.01 Change % -6.67 Tick N/A
Bid 0.14 Bid Size 1,500.00 Ask 0.15 Ask Size 144,500.00
Open 0.14 High 0.16 Low 0.13 Prev Close 0.15
Last Trade Volume 691,250 52 Wk Hi 0.32 52 Wk Low 0.065
Market Cap 7.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 54,752,024.00 EPS (TTM) -0.03 PE Ratio N/A Exchange CSE

News